EE03966B1 - Valuvaigistava toimega ühendid ja nende valmistamise meetod - Google Patents

Valuvaigistava toimega ühendid ja nende valmistamise meetod

Info

Publication number: EE03966B1
Authority: EE; Estonia
Prior art keywords: compounds; preparation; analgesic activity; analgesic; activity
Prior art date: 1996-12-20

Application number

EEP199900261A

Other languages

English (en)

Other versions

EE9900261A (et

Inventor

Pelcman Benjamin

Roberts Edward

Original Assignee

Astra Pharma Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-20

Filing date

1997-12-09

Publication date

2003-02-17

1997-12-09 Application filed by Astra Pharma Inc. filed Critical Astra Pharma Inc.

2000-02-15 Publication of EE9900261A publication Critical patent/EE9900261A/et

2003-02-17 Publication of EE03966B1 publication Critical patent/EE03966B1/et

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0446—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Optics & Photonics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pyrrole Compounds (AREA)

EEP199900261A 1996-12-20 1997-12-09 Valuvaigistava toimega ühendid ja nende valmistamise meetod EE03966B1 (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9604786A SE9604786D0 (sv)	1996-12-20	1996-12-20	New compounds
PCT/SE1997/002051 WO1998028270A1 (en)	1996-12-20	1997-12-09	Novel compounds with analgesic effect

Publications (2)

Publication Number	Publication Date
EE9900261A EE9900261A (et)	2000-02-15
EE03966B1 true EE03966B1 (et)	2003-02-17

Family

ID=20405139

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP199900261A EE03966B1 (et)	1996-12-20	1997-12-09	Valuvaigistava toimega ühendid ja nende valmistamise meetod

Country Status (31)

Country	Link
US (3)	US6153626A (et)
EP (2)	EP1428821A1 (et)
JP (1)	JP2001507021A (et)
KR (1)	KR20000069600A (et)
CN (2)	CN1539824A (et)
AR (1)	AR010378A1 (et)
AT (1)	ATE266638T1 (et)
AU (1)	AU738002B2 (et)
BR (1)	BR9713785A (et)
CA (1)	CA2274117A1 (et)
CZ (1)	CZ220099A3 (et)
DE (1)	DE69729115T2 (et)
DK (1)	DK0946510T3 (et)
EE (1)	EE03966B1 (et)
ES (1)	ES2219783T3 (et)
HU (1)	HUP0000613A3 (et)
ID (1)	ID21662A (et)
IL (1)	IL130536A0 (et)
IS (1)	IS5078A (et)
MY (1)	MY132705A (et)
NO (1)	NO313632B1 (et)
NZ (1)	NZ336028A (et)
PL (1)	PL188945B1 (et)
PT (1)	PT946510E (et)
RU (1)	RU2193030C2 (et)
SE (1)	SE9604786D0 (et)
SK (1)	SK283300B6 (et)
TR (1)	TR199901411T2 (et)
UA (1)	UA54481C2 (et)
WO (1)	WO1998028270A1 (et)
ZA (1)	ZA9711049B (et)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9504661D0 (sv)	1995-12-22	1995-12-22	Astra Pharma Inc	New compounds
TW548271B (en) *	1996-12-20	2003-08-21	Astra Pharma Inc	Novel piperidine derivatives having an exocyclic double bond with analgesic effects
SE9604786D0 (sv) *	1996-12-20	1996-12-20	Astra Pharma Inc	New compounds
US6974825B1 (en)	1996-12-20	2005-12-13	Astrazeneca Canada Inc.	Compounds with analgesic effect
EP1049676B1 (en) *	1997-12-24	2005-10-12	Ortho-Mcneil Pharmaceutical, Inc.	4- aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor
AU2003220725B2 (en) *	1997-12-24	2006-06-01	Ortho-Mcneil Pharmaceutical, Inc.	4-[aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor
US6900228B1 (en)	1998-03-10	2005-05-31	Research Triangle Institute	Opiate compounds, methods of making and methods of use
CA2683097A1 (en) *	1998-03-10	1999-09-16	Research Triangle Institute	Novel opiate compounds, methods of making and methods of use
US6436959B1 (en)	1998-12-23	2002-08-20	Ortho-Mcneil Pharmaceutical, Inc.	4-[aryl(piperidin-4-yl)]aminobenzamides
SE9904675D0 (sv) *	1999-12-20	1999-12-20	Astra Pharma Inc	Novel compounds
SE9904674D0 (sv)	1999-12-20	1999-12-20	Astra Pharma Inc	Novel compounds
SE9904673D0 (sv) *	1999-12-20	1999-12-20	Astra Pharma Inc	Novel compounds
JP2003518119A (ja) *	1999-12-22	2003-06-03	オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド	４−［アリール（８−アザビシクロ［３．２．１］オクタン−３−イル）］アミノ安息香酸誘導体
ATE302184T1 (de) *	2000-02-18	2005-09-15	Meiji Seika Kaisha	Phenoxyalkylaminderivate als agonisten des opioid-delta rezeptors
CN1426411A (zh)	2000-03-03	2003-06-25	奥索-麦克尼尔药品公司	3－(二芳基亚甲基)－8－氮杂双环[3.2.1]辛烷衍生物
EP1277737A4 (en)	2000-03-24	2003-05-07	Meiji Seika Kaisha	DIPHENYLALKYLAMINE DERIVATIVES AS AGONISTS OF THE OPIOID -g (d) RECEPTOR
SE0001209D0 (sv)	2000-04-04	2000-04-04	Astrazeneca Canada Inc	Novel compounds
US6887876B2 (en)	2000-12-14	2005-05-03	Ortho-Mcneil Pharmaceutical, Inc.	Benzamidine derivatives
CA2436263A1 (en) *	2000-12-15	2002-06-20	Astrazeneca Ab	New process for the preparation diaryl-4-amino-piperidinyl compounds
SE0101770D0 (sv)	2001-05-18	2001-05-18	Astrazeneca Ab	Novel compounds
SE0101769D0 (sv) *	2001-05-18	2001-05-18	Astrazeneca Ab	Novel compounds
SE0101773D0 (sv)	2001-05-18	2001-05-18	Astrazeneca Ab	Novel compounds
SE0101771D0 (sv) *	2001-05-18	2001-05-18	Astrazeneca Ab	Novel compounds
EP1395567B1 (en)	2001-05-18	2009-01-14	AstraZeneca AB	4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
EP1438304B1 (en)	2001-10-15	2006-12-06	Janssen Pharmaceutica N.V.	Novel substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists
WO2003076400A1 (en) *	2002-03-13	2003-09-18	Janssen Pharmaceutica N.V.	New inhibitors of histone deacetylase
NZ536504A (en)	2002-05-24	2008-04-30	Millennium Pharm Inc	CCR9 inhibitors and methods of use thereof
SE0203300D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
SE0203302D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
SE0203303D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
US7420055B2 (en)	2002-11-18	2008-09-02	Chemocentryx, Inc.	Aryl sulfonamides
US7741519B2 (en)	2007-04-23	2010-06-22	Chemocentryx, Inc.	Bis-aryl sulfonamides
DE60314175T2 (de)	2002-11-18	2008-01-24	Chemocentryx Inc., Mountain View	Arylsulfonamide
US7227035B2 (en)	2002-11-18	2007-06-05	Chemocentryx	Bis-aryl sulfonamides
EP1587789B1 (en) *	2003-01-16	2008-09-03	Acadia Pharmaceuticals Inc.	Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
AU2004253898A1 (en)	2003-06-27	2005-01-13	Janssen Pharmaceutica N.V.	Tricyclic delta opioid modulators
US7435822B2 (en)	2004-02-03	2008-10-14	Janssen Pharmaceutica N.V.	3-(diheteroarylmethylene)-8-azabicyclo[3.2.1]octane and 3-((aryl)(heteroaryl)methylene)-8-azabicyclo[3.2.1]octane derivatives
MX2007001240A (es)	2004-08-02	2007-03-23	Astrazeneca Ab	Derivados de diarilmetil-piperazina, preparaciones y usos de las mismas.
JP2008529971A (ja) *	2004-08-05	2008-08-07	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	三環式δ−オピオイド調節剤
WO2006069275A1 (en) *	2004-12-22	2006-06-29	Janssen Pharmaceutica N.V.	Tricyclic delta-opioid modulators
JP2008525482A (ja)	2004-12-22	2008-07-17	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	三環式ｏ−オピオイド調節剤
MX2007007627A (es) *	2004-12-22	2008-01-28	Johnson & Johnson	Moduladores delta-opioides triciclicos.
AU2006203880A1 (en) *	2005-01-06	2006-07-13	Janssen Pharmaceutica N.V.	Tricyclic delta-opioid modulators
TWI439452B (zh) *	2005-05-13	2014-06-01	Otsuka Pharma Co Ltd	吡咯烷化合物（二）
AR057374A1 (es) *	2005-06-16	2007-11-28	Janssen Pharmaceutica Nv	Moduladres opioides triciclicos y composiciones farmaceuticas y veterinarias
JP5219465B2 (ja) *	2006-11-10	2013-06-26	大塚製薬株式会社	医薬

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4091096A (en) *	1976-03-19	1978-05-23	Eli Lilly And Company	Dinitroanilines for the control of phytopathogens
EG12406A (en) *	1976-08-12	1979-03-31	Janssen Pharmaceutica Nv	Process for preparing of novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
SE441448B (sv) *	1977-05-23	1985-10-07	Pfizer	Sett att framstella hexahydro-gamma-karbolinforeningar
DE3200304A1 (de) *	1981-01-16	1982-08-26	Sandoz-Patent-GmbH, 7850 Lörrach	3-aminopropoxyaryl-derivate, ihre herstellung und sie enthaltende arzneimittel
EP0181793B1 (fr) *	1984-10-16	1988-07-27	Synthelabo	Dérivés de pipéridine, leur préparation et leur application en thérapeutique
YU150489A (sh)	1989-08-10	1992-12-21	W.L. Gore & Co. Gmbh.	Uređaj za ispitivanje odevnih predmeta na nepromočivost
KR940003491B1 (ko)	1989-08-10	1994-04-23	리히터 게데온 베기에스제티 기아르 알.티	4,4-이중 치환된 피페리딘 유도체와 그 제조방법 및 상기 화합물을 함유하는 약제학적 조성물
SE8904298D0 (sv) *	1989-12-21	1989-12-21	Astra Ab	New compounds
GB9202238D0 (en) *	1992-02-03	1992-03-18	Wellcome Found	Compounds
US5854245A (en) *	1996-06-28	1998-12-29	Merck & Co., Inc.	Fibrinogen receptor antagonists
TW548271B (en) *	1996-12-20	2003-08-21	Astra Pharma Inc	Novel piperidine derivatives having an exocyclic double bond with analgesic effects
SE9604786D0 (sv)	1996-12-20	1996-12-20	Astra Pharma Inc	New compounds
EP1049676B1 (en) *	1997-12-24	2005-10-12	Ortho-Mcneil Pharmaceutical, Inc.	4- aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor
CA2683097A1 (en)	1998-03-10	1999-09-16	Research Triangle Institute	Novel opiate compounds, methods of making and methods of use
US6436959B1 (en)	1998-12-23	2002-08-20	Ortho-Mcneil Pharmaceutical, Inc.	4-[aryl(piperidin-4-yl)]aminobenzamides

1996
- 1996-12-20 SE SE9604786A patent/SE9604786D0/xx unknown
1997
- 1997-09-12 UA UA99074131A patent/UA54481C2/uk unknown
- 1997-12-09 PT PT97950539T patent/PT946510E/pt unknown
- 1997-12-09 AU AU53513/98A patent/AU738002B2/en not_active Ceased
- 1997-12-09 JP JP52867098A patent/JP2001507021A/ja not_active Ceased
- 1997-12-09 AT AT97950539T patent/ATE266638T1/de not_active IP Right Cessation
- 1997-12-09 EE EEP199900261A patent/EE03966B1/et not_active IP Right Cessation
- 1997-12-09 BR BR9713785-5A patent/BR9713785A/pt unknown
- 1997-12-09 NZ NZ336028A patent/NZ336028A/en unknown
- 1997-12-09 DE DE69729115T patent/DE69729115T2/de not_active Expired - Fee Related
- 1997-12-09 CA CA002274117A patent/CA2274117A1/en not_active Abandoned
- 1997-12-09 CN CNA2004100324204A patent/CN1539824A/zh active Pending
- 1997-12-09 EP EP04002901A patent/EP1428821A1/en not_active Withdrawn
- 1997-12-09 SK SK763-99A patent/SK283300B6/sk unknown
- 1997-12-09 ZA ZA9711049A patent/ZA9711049B/xx unknown
- 1997-12-09 CZ CZ992200A patent/CZ220099A3/cs unknown
- 1997-12-09 TR TR1999/01411T patent/TR199901411T2/xx unknown
- 1997-12-09 DK DK97950539T patent/DK0946510T3/da active
- 1997-12-09 ES ES97950539T patent/ES2219783T3/es not_active Expired - Lifetime
- 1997-12-09 KR KR1019997005586A patent/KR20000069600A/ko not_active Ceased
- 1997-12-09 EP EP97950539A patent/EP0946510B1/en not_active Expired - Lifetime
- 1997-12-09 IL IL13053697A patent/IL130536A0/xx unknown
- 1997-12-09 PL PL97334370A patent/PL188945B1/pl not_active IP Right Cessation
- 1997-12-09 WO PCT/SE1997/002051 patent/WO1998028270A1/en not_active Ceased
- 1997-12-09 US US09/029,468 patent/US6153626A/en not_active Expired - Lifetime
- 1997-12-09 CN CNB971808376A patent/CN1154635C/zh not_active Expired - Fee Related
- 1997-12-09 HU HU0000613A patent/HUP0000613A3/hu unknown
- 1997-12-09 ID IDW990536A patent/ID21662A/id unknown
- 1997-12-09 RU RU99115746/04A patent/RU2193030C2/ru not_active IP Right Cessation
- 1997-12-19 AR ARP970106076A patent/AR010378A1/es active IP Right Grant
- 1997-12-19 MY MYPI97006174A patent/MY132705A/en unknown
1999
- 1999-06-11 IS IS5078A patent/IS5078A/is unknown
- 1999-06-18 NO NO19993023A patent/NO313632B1/no unknown
2000
- 2000-08-25 US US09/645,565 patent/US6399635B1/en not_active Expired - Fee Related
2002
- 2002-04-15 US US10/121,683 patent/US6710179B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
NO993023D0 (no)	1999-06-18
EP0946510A1 (en)	1999-10-06
BR9713785A (pt)	2000-02-08
ATE266638T1 (de)	2004-05-15
NO993023L (no)	1999-08-12
PT946510E (pt)	2004-08-31
MY132705A (en)	2007-10-31
UA54481C2 (uk)	2003-03-17
PL334370A1 (en)	2000-02-28
NZ336028A (en)	2001-03-30
AU738002B2 (en)	2001-09-06
CN1154635C (zh)	2004-06-23
IS5078A (is)	1999-06-11
EP1428821A1 (en)	2004-06-16
US6153626A (en)	2000-11-28
US20030055045A1 (en)	2003-03-20
AU5351398A (en)	1998-07-17
DE69729115T2 (de)	2005-04-28
CA2274117A1 (en)	1998-07-02
EP0946510B1 (en)	2004-05-12
TR199901411T2 (xx)	1999-09-21
KR20000069600A (ko)	2000-11-25
EP1428821A8 (en)	2005-01-26
CN1539824A (zh)	2004-10-27
DK0946510T3 (da)	2004-08-09
RU2193030C2 (ru)	2002-11-20
DE69729115D1 (de)	2004-06-17
ES2219783T3 (es)	2004-12-01
AR010378A1 (es)	2000-06-07
HUP0000613A2 (hu)	2000-09-28
ID21662A (id)	1999-07-08
JP2001507021A (ja)	2001-05-29
CZ220099A3 (cs)	1999-11-17
EE9900261A (et)	2000-02-15
IL130536A0 (en)	2000-06-01
HK1023996A1 (en)	2000-09-29
HUP0000613A3 (en)	2002-10-28
US6399635B1 (en)	2002-06-04
ZA9711049B (en)	1998-06-22
SK76399A3 (en)	2000-01-18
HK1022910A1 (en)	2000-08-25
WO1998028270A1 (en)	1998-07-02
US6710179B2 (en)	2004-03-23
NO313632B1 (no)	2002-11-04
CN1241178A (zh)	2000-01-12
SK283300B6 (sk)	2003-05-02
PL188945B1 (pl)	2005-05-31
SE9604786D0 (sv)	1996-12-20

Publication	Publication Date	Title
EE03966B1 (et)	2003-02-17	Valuvaigistava toimega ühendid ja nende valmistamise meetod
FI960751A7 (fi)	1996-02-19	Substituoidut atsaindolylideeniyhdisteet ja menetelmä niiden valmistamiseksi
FI955051A7 (fi)	1996-04-25	Heterosyklisiä yhdisteitä ja niiden valmistus ja käyttö
EE03976B1 (et)	2003-02-17	Erütromütsiinid ja nende valmistamise meetod
FI941137L (fi)	1994-09-12	2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi
FI973426L (fi)	1997-10-20	Bentsopyraania sisältävät yhdisteet ja menetelmä niiden valmistamiseksi
FI964028L (fi)	1996-10-08	Uusi farmaseuttinen formulaatio ja menetelmä
FI973750A0 (fi)	1997-09-22	2-metyylitienobentsodiatsepiinin valmistus ja kiteiset muodot
EE9800459A (et)	1999-06-15	Spiro-piperidiini derivaadid ja nende kasutamine terapeutiliste toimeainetena
FI941787A7 (fi)	1994-10-20	Sähkökirurginen prosessori ja menetelmä sen käyttämiseksi
FI972165A0 (fi)	1997-05-21	Aerogeelipitoinen komposiittimateriaali, menetelmä sen valmistamiseksi ja sen käyttö
FI973733L (fi)	1999-03-20	Farmaseuttinen valmiste ja menetelmä sen valmistamiseksi
FI971412A7 (fi)	1997-04-04	Peptididyyliyhdisteet ja niiden terapeuttinen käyttö metalloproteaasie n estäjinä
FI945912L (fi)	1995-02-15	Proteinoidikantajat ja menetelmät niiden valmistamiseksi sekä niiden käyttö
FI972622L (fi)	1997-06-18	Pitkävaikutteisia rakeisia valmisteita ja niiden valmistusmenetelmä
FI945166A7 (fi)	1995-05-05	Katalyttejä, niiden käyttömenetelmä ja menetelmä niiden valmistamiseksi
FI944961L (fi)	1994-10-21	Farmaseuttinen valmiste ja menetelmä sen valmistamiseksi
FI964102L (fi)	1996-12-11	Menetelmä fenolin ja fenolijohdannaisten valmistamiseksi
FI962908L (fi)	1998-01-20	Mikrobinvastainen koostumus, sen valmistusmenetelmä ja sen käyttö
FI972245A7 (fi)	1997-07-16	Meso-monojodisubstituoidut tetramakrosykliset yhdisteet sekä niiden valmistus- ja käyttömenetelmät
FI980246A0 (fi)	1998-02-04	Menetelmä keittimen käyttämiseksi ja keitin
FI943383L (fi)	1994-08-31	Yhdiste FO-1289 ja menetelmä sen valmistamiseksi
FI932992A7 (fi)	1993-12-31	Fungisiidisia fenyylibentsamideja ja menetelmät niiden valmistamiseksi
NO964190D0 (no)	1996-10-03	Terapeutisk smertestillende middel samt fremgangsmåte ved fremstilling derav
FI963128L (fi)	1996-08-09	Uusia analgeettisesti ja paikallisanesteettisesti vaikuttavia yhdisteitä

Legal Events

Date	Code	Title	Description
2004-02-16	KB4A	Valid patent at the end of a year	Effective date: 20031231
2005-02-15	KB4A	Valid patent at the end of a year	Effective date: 20041231
2006-02-15	KB4A	Valid patent at the end of a year	Effective date: 20051231
2006-08-15	MM4A	Lapsed by not paying the annual fees	Effective date: 20051209